Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Revenue (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Revenue for 3 consecutive years, with $348000.0 as the latest value for Q4 2025.

  • Quarterly Revenue fell 46.63% to $348000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2025, up 436.5% year-over-year, with the annual reading at $3.5 million for FY2025, 436.5% up from the prior year.
  • Revenue hit $348000.0 in Q4 2025 for Camp4 Therapeutics, down from $795000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.5 million in Q2 2025 to a low of $348000.0 in Q4 2025.
  • Historically, Revenue has averaged $750000.0 across 3 years, with a median of $723500.0 in 2024.
  • Biggest YoY gain for Revenue was 46.63% in 2025; the steepest drop was 46.63% in 2025.
  • Year by year, Revenue stood at $350000.0 in 2023, then skyrocketed by 86.29% to $652000.0 in 2024, then crashed by 46.63% to $348000.0 in 2025.
  • Business Quant data shows Revenue for CAMP at $348000.0 in Q4 2025, $795000.0 in Q3 2025, and $1.5 million in Q2 2025.